BlackRock launches iShares US biotech ETF

TER of 0.35%

Tom Eckett
clock • 1 min read

BlackRock has launched the iShares Nasdaq US Biotechnology UCITS ETF investing directly in biotech and pharmaceutical stocks which are listed on the Nasdaq stock exchange.

Listed on the London Stock Exchange on 23 October, the ETF has a total expense ratio (TER) of 0.35% and will track the Nasdaq Biotechnology index. The index, which has 161 stocks, is calculated using a modified cap-weighted methodology. The top five constituents are capped at 8% of the total index, while the remaining holdings are capped at 4%. The top five holdings are Biogen, Amgen, Celgene Corp, Gilead Sciences and Regeneron Pharmaceuticals. Does recent tech sell-off signal 'beginning of the end' for turbo-charged rally? The firm said the market's focus on aging demographics ...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on ETFs

Join Investment Week in London to discuss the future of ETFs

Join Investment Week in London to discuss the future of ETFs

Amundi, BNP Paribas, UBS and Research in Finance confirmed to speak

Katrina Lloyd
clock 23 June 2025 • 2 min read
European asset managers using Taiwan as testing ground for active ETFs

European asset managers using Taiwan as testing ground for active ETFs

Race for active ETFs hots up

Linus Uhlig
clock 23 June 2025 • 3 min read
Active ETFs defend stewardship capabilities in face of shareholder engagement crisis

Active ETFs defend stewardship capabilities in face of shareholder engagement crisis

Record number of active ETF launches in 2025

Sorin Dojan
clock 18 June 2025 • 6 min read
Trustpilot